FR2974117A1 - METHOD FOR QUANTIFICATION OF LIVING BACTERIA IN A LIQUID MEDIUM - Google Patents

Abstract

The present invention relates to a method for quantifying living bacteria in a liquid medium capable of containing it, characterized in that the following successive stages are carried out in which: 1 / yeasts are added to said sample and a mixture is produced under stirring, and 2 / an inhibiting compound is added capable of binding and thus preventing amplification by PCR of the DNA of dead bacteria, and 3 / the sample is heated to a temperature of not more than 100 ° C for 5 to 10 minutes, so as to lyse all the bacteria without causing lysis of the yeasts, and 4 / a fraction containing all the yeasts and debris of lysed bacteria is separated and a fraction containing the bacterial DNA is recovered, and 5 / uses quantification by amplification by PCR, preferably by real-time PCR, of the DNA originating from said bacteria initially living in the initial sample.

Description

The present invention relates to a method for quantifying living bacteria in an aqueous medium capable of containing them.

The present invention more particularly relates to a method for quantifying living bacteria in an aqueous sample that may contain a mixture of dead and living cells. More particularly, the present invention relates to a method of quantifying living bacteria of the enterococci and Escherichia coli genus, contained in a bathing water sample and, more particularly, seawater. The method according to the invention is useful because there are regulatory health standards for the concentration of said live E. coli bacteria and enterococci not to be exceeded in said bathing waters, namely, in particular, not more than 10 E. coli bacteria / ml and 370 enterococci / 100 ml. by E. coli bacteria, all pathogenic and non-pathogenic subspecies of Escherichia coli.

The reference methods for carrying out these quantifications of E. coli and enterococci bacteria in the bathing water samples comprise cell cultures of said bacteria in said sample and quantification by measurement of the enzymatic activity (Standard methods references NF T 90- 432 (for the search for enterococci) and NF T 90-433 (for the research of E. Coli). In this reference method, the extraction of said bacteria and the quantification of DNA are not carried out. this type of method is a duration and therefore an important time of rendering results, ie requiring an incubation of about 48 hours), as well as a specificity as to the detected bacteria insufficient and a lack of precision of the results especially for low values. A method is also known in which the bacteria are extracted from the sample by filtration on membranes, then the RNA is extracted from said bacteria by cell lysis and the chromosomal DNA is quantified by an RT PCR method in which the cells are transformed. RNA into DNA. The advantage of this method is that the RNA of the dead bacteria degrades so that during the amplification quantisation step, only the DNA of the living bacteria is quantified. However, this method has the following drawbacks. The fragility of RNA makes the technique very delicate and imposes drastic handling conditions, including drastic conditions for decontamination of equipment and reagents. On the other hand, quantification is preceded by a reverse transcription step to transform RNA into cDNA. This step can introduce a bias in the quantification, and shows that one does not quantify the target directly. In addition, the production of RNase enzyme and therefore the amount of RNA in a bacterial cell can vary according to its physiological state. Thus, in a state of nutritional deficiency as in bathing waters, the bacterium produces RNase which will degrade its ribosomal RNAs The object of the present invention is to provide a method for extracting and quantifying living bacteria in bathing waters, either at the same time, more efficient in terms of sensitivity of extraction, detection and quantification, and simple and less expensive to industrialize. To this end, the present invention provides a method for quantifying living bacteria in a liquid medium, preferably an aqueous medium, capable of containing them, characterized in that the following successive steps are carried out in which: a / it is added yeast in said sample and mixing is carried out with stirring, and b / separating a solid residue consisting of a precipitate containing all yeasts and bacteria contained in said sample, c / re-suspend said solid residue in a buffered solution at a pH of 7 to 8, preferably a 40 mM Tris buffer at pH 7.6, and a chemical or biological compound, capable under concentration and / or treatment conditions, of causing the binding of said compound to be added thereto; specifically to the DNA of dead bacteria without causing lysis or degradation of the walls of living bacteria nor the DNA binding of living bacteria, said compound referred to as inhi compound biteur being able to thus prevent PCR amplification of the DNA which is bound to it, and d / separating a fraction containing a solid residue containing all the yeasts and bacteria, and e) heating said solid residue, preferably to bath, at a temperature of not more than 100 ° C, preferably at 95 ° C for 5 to 10 minutes, so as to lyse all the bacteria without causing lysis of the yeasts, and f / a fraction containing all the yeasts and debris of lysed bacteria and a fraction containing the bacterial DNA is recovered, and quantification by PCR amplification, preferably by real-time PCR, of the DNA originating from said initially living bacteria in the lysed starting sample. In step a /, the yeasts seem to have a "trapping" effect and / or effect on the bacteria. This step a / avoids having to implement in step b) a step of separating the bacteria by filtration during which there are necessarily losses when the stall of bacteria on the filters of a On the other hand, it avoids the use of commercially available chemical precipitators, which are relatively more expensive. In step c), said inhibiting compound is used under the concentration and treatment conditions capable of causing said binding of said compound to the DNA of dead bacteria.

A first aspect of the invention is therefore to have discovered this technical effect of yeasts, namely this new use of yeasts as a precipitating agent in the extraction of bacteria, namely that in step a /, the yeasts entrain or retain all the dead and living bacteria of the tested liquid sample, and - in step d1, thus eliminating said inhibitor compound and other possible molecules present in the initial sample that may affect the subsequent steps and in step e /, the yeasts resist for up to 15 minutes at a temperature of 95 to 100 ° C., so that, in practice, to achieve the breakdown of the bacterial walls of dead bacteria and living bacteria, a heating of 5 minutes is sufficient, without affecting the yeast wall. Step e / therefore makes it possible to recover later (in step f /) the bacterial DNA, namely the DNA originating from the dead bacteria bound to the inhibiting compound and the DNA not bound to the inhibitory compound from the initially living bacteria, and not the yeast DNA, which would be detrimental to the sensitivity of the PCR of step g /, given the relatively large amount of yeasts initially used.

This step e / avoids the implementation of chemical lysis followed by column purification to reduce costs. The heating also has the advantage of avoiding the use of expensive detergent and specific purification column, it being further understood that said detergents may have an inhibiting effect on the performance of the subsequent PCR. The tests carried out demonstrate that in step d1, at least 99% of the bacteria initially contained in the sample are recovered. The interest of the invention essentially results from the double advantageous technical effect of the implementation of yeasts as precipitating agent thus promoting the extraction of bacteria without hindering the selective extraction of bacterial DNA in the case of a step of extracting DNA by heating, the yeast DNA is not recovered on the one hand, and secondly, the bacterial DNA is not degraded. It is the combination of the implementation of yeasts as a precipitating agent of bacteria on the one hand, and a simple and inexpensive DNA extraction process by heating to 95-100 ° C. a solution of the bacterial pellet and yeast, which are at the origin of the advantageous results of the invention. In step f /, the bacterial DNA comprises the non-degraded DNA of the initially living bacteria and the DNA bound to said inhibitory compound resulting from the lysis of the initially dead bacteria. The process according to the invention therefore consists essentially in firstly in recovering all the cells present in the aqueous sample, then in removing the DNA from the dead cells, before extracting and purifying the DNA of the cells. live bacteria. Finally, the resulting DNA is sufficiently pure to be quantified by real-time PCR. The process according to the present invention can be carried out in less than 4 hours and is more accurate than the comparative reference method.

More particularly, in step g /, the quantification of living bacteria of the enterococci and Escherichia coli genus contained in a bathing water sample is carried out. According to another advantageous particular characteristic, in step b /, the sample is centrifuged at least 5,000 g in a container for at least 10 minutes and the pellet is recovered by removal of the supernatant. This minimum speed of 5000 g makes it possible to obtain a cellular recovery yield of more than 99%. At speeds below 5000 g, the centrifugation time must be increased considerably to achieve a cell recovery efficiency of more than 99%. Centrifugation rates above 5000 g are suitable but do not allow to reduce the centrifugation times. Even more particularly, in step a), Saccharomyces cerevisiae baker's yeast is used, the yeast concentration being adjusted to 200 to 400 μg / ml, preferably about 300 μg / ml. At this concentration of 200 μg / ml, the yeasts form a cell sieve which precipitates all the bacterial cells, preferably under the action of the centrifugal force when the separation is carried out by centrifugation. At concentrations above 400 μg / ml, the pellet becomes too large and does not remain attached to the bottom of the container. Advantageously, in the step, a coagulant protein such as bovine serum albumin (BSA) at a concentration of 2 to 20 mg / ml in the sample is added to the sample in order to promote the adhesion of the pellet to the wall of the centrifugation vessel in step b /. At too high concentrations of coagulating proteins, it becomes difficult to rehydrate and re-suspend the solid residue in step c1, on the one hand, and, on the other hand, the efficiency of step e / heating may be affected by coagulation of said protein. In a preferred embodiment, in the step said inhibiting compound is a photo-activatable intercalating agent and the suspension is subjected to a light irradiation treatment for activating the binding of said intercalating agent with the DNA of the dead bacteria, said intercalating agent inhibiting PCR amplification of said DNA to which it is bound. It is known to those skilled in the art, in particular in WO 01/77379 and WO 2007/100762, that certain interfering photoactivatable agents can bind specifically with the DNA of dead bacteria, whose membrane wall is degraded or lysed, then to intercalate with the DNA of the dead bacteria, without being able to penetrate inside the living bacteria and, thus, without binding to the DNA of the living bacteria. The dead bacteria have their wall weakened, made permeable, even torn, which allows an intercalating agent to cross the wall and enter the cell to reach its DNA because the bacteria are non-nucleated organisms and their DNA is not protected by a membrane inside the bacterium. This intercalation inhibits the PCR amplification of the DNA. The DNA of the dead cells as well as the free DNA strands bound to the intercalating agent in the sample are then no longer quantifiable by PCR, which makes the specific method of the living cells because the intercalating agent remains blocked at the level of the wall of living bacteria, and therefore allows the step g / quantify specifically only the DNA of living bacteria by PCR amplification, since the photoactivatable intercalator agent is not related thereto. More particularly, according to the present invention, said intercalating agent is an ethidium azide, preferably EMA, at a concentration of 2 to 5 μg / ml and the suspension is subjected to light irradiation, maintaining a suspension temperature. at room temperature, preferably by soaking the container containing it in the ice. In the presence of light and thanks to its particular chemical function, especially azide, in the case of EMA, the intercalating agent can couple to the DNA covalently. More particularly, light irradiation is achieved by placing the suspension under a 150 Watt halogen lamp at 20 cm for at least 10 minutes. The EMA compound is particularly interesting because of its low cost and the fact that the use of EMA unlike PMA requires very low concentrations for the treatment of the DNA of dead bacteria (2 to 5 μg / ml for the EMA instead of 100 μg / ml for the PMA) the risk for the user is therefore much less important because of the carcinogenic nature of these mutagenic molecules. According to another advantageous characteristic, in step d1, said centrifugal separation of the suspension obtained after the treatment of step c1 is carried out at least 5,000 g for at least 10 minutes and elimination of the greater part supernatant to recover the pellet containing said solid residue containing all yeasts and bacteria in a small fraction of at least 500 μl of said suspension, and heated in step e). Here again, at speeds below 5000 g, the centrifugation time must be considerably increased to obtain a cell recovery efficiency of more than 99%. Higher centrifugation speeds are suitable but do not make it possible to reduce the centrifugation times. More particularly still, in step f /, the said separation by centrifugation of the suspension obtained after the treatment of step c / is carried out at least 5000 g for at least 5 minutes and removal of the pellet containing the intact yeasts. and the debris of lysed bacteria, to recover the supernatant containing said bacterial DNA. Again, at speeds below 5000 g, the centrifugation time must be considerably increased to pellet all yeasts and cell debris, higher centrifugation speeds are appropriate. Even more particularly, in step g /, a preliminary step is carried out for purification of the bacterial DNA, preferably on a silica column or a 30 KDa threshold membrane filtration column.

The threshold of 30 KDa is chosen because the bacterial chromosomes have at least 3.106 bases. In known manner, these filtration columns have a hydrophilic membrane which will retain the bacterial DNA, without fixing it. All other residual molecules and salts will be removed in the filtrate. DNA retained in a small volume of TE will be recovered by flipping the column over a clean tube. This purification step makes it possible to eliminate proteins and RNAs released by the bacteria or else residual traces of inhibiting compound such as EMA or other molecules possibly present in the initial sample, so that the subsequent quantification by PCR is as reliable as possible by eliminating any impurities from the sample that may affect the reliability and specificity of the PCR amplification, in particular that may affect the action of a polymerase enzyme, among others.

More particularly, in step g / the E. coli and enterococci bacteria are amplified with the following pair of primers - for E. coli bacteria: a specific sequence of E. coli derived from the 16S gene, and - for the enterococci bacteria: a specific sequence of the genus Enterococcus derived from the tuf gene. The 2 specific sequences above were chosen because they make it possible to carry out amplification cycles and a quantification under the same conditions and according to the same protocol for the 2 sequences. A classical PCR can be carried out with Sybr Green as fluorochrome, the amplification being able to be carried out simultaneously on the same plate because the PCR protocols are identical, the quantification of each species however requiring separate wells for each analysis. Advantageously, for the quantification, the amplification of a range of chromosomal DNA standards of said living bacteria and / or a calibration range of non-bacterial synthetic DNA called alien DNA at various known concentrations. In the latter case at step g / the DNA sample is added to quantify a known concentration of said alien DNA as an internal control. the following oligonucleotides chosen from: - SEQ. ID. Nos. 1 and 2 for the 5 'and 3' primers for the amplification of the sequence derived from the 16S gene of the E. Coli bacterium, and - SEQ. ID. Nos. 3 and 4 for the 5 'and 3' primers for the amplification of the sequence derived from the tufa gene of enterococci bacteria, and - SEQ. ID. No. 5 for the internal control sequence of alien DNA, and SEQ. ID. No. 6 and 7 for the primers 5 'and 3' of the sequence SEQ. ID. # 5.

SEQ DNA sequences. ID. Nos. 1 to 7 are described in the sequence listing appended to the description. The extraction and quantification steps of the process according to the invention are sufficiently sensitive to detect concentrations of 2 to 108 living bacteria / ml of samples. The maximum threshold of 108 bacteria is related to a problem of sensitivity of PCR while the minimum threshold of 2 bacteria / ml is related to both the extraction performance and sensitivity of the PCR. Other features and advantages of the present invention will become apparent from the following detailed examples of embodiment. Example 2 refers to the following Figures 1 to 3 in which: - Figure 1 shows the effects of the concentration of ethidium azide on samples consisting solely of living bacteria or only dead bacteria or on mixed samples containing live bacteria and dead bacteria, with an illumination time of 20 minutes, the following 3 EMA concentrations having been tested: 3 μg / ml, 6 μg / ml and 12 μg / ml.

In Fig. 1, the following symbols have the following meanings: sample with living bacteria only sample with dead bacteria only sample with live and dead bacteria - Fig. 2 shows the effects of treating ethidium azide at 3 μg / ml with variable elimination times (10 min and 20 min) on live bacteria samples, or samples consisting of dead bacteria or mixed samples containing dead bacteria and live bacteria. In Figure 2, the following symbols have the following meanings: sample with living bacteria only: sample with dead bacteria only: sample with living and dead bacteria 0: without EMA - Figure 3 represents the yield (%) of the step extraction of DNA by heating as a function of incubation time (t) at 95 ° C (from 0 to 15 minutes). EXAMPLE 1 Quantification of E. coli and Enterococcus present in a sample of aqueous medium The following five successive steps were carried out: 1 / - recovery and concentration of all the cells by centrifugation using a specific and innovative precipitant (This step 1 corresponds to the steps a / and b /) defined above); 2 / - destructuring DNA of dead bacteria and free DNA in the sample by treatment with EMA (this step 2 corresponds to step c / defined above); 3 / -recovery and total lysis of the cells by heating the sample and separating the DNA from the rest of the sample (this step 3 corresponds to the steps d / to f / defined above); 4 / -purification of the DNA on a silica column or by membrane filtration (this step is included in step f / defined above); 5 / - quantification of the DNA by quantitative PCR (this step is included in step g / defined above). 1 / - Stage of recovery of all the bacteria Centrifugation makes it possible to concentrate the sample and to separate the cell pellets from the supernatants. The major difficulty with centrifugation is that at cell concentrations of less than 10 bacteria / ml, even at speeds up to 17,000 xg for relatively long durations (20 min), the cell recovery efficiency is rarely greater than 60% and even for samples whose bacterial concentration is greater than 10 '/ ml centrifugation of 15 minutes to 17,000 xg / ne can recover only 95% of the bacteria in the pellet. This is why according to the present invention, there is added a precipitant hitherto never used for this purpose: Saccharomyces cerevisiae, known as baker's yeast. Yeasts are microorganisms, unicellular fungi of 5 to 6 pm, able to sporulate and therefore easy to preserve. Highly resistant, their walls allow them to survive dehydration and high temperatures. Thus, the baker's yeast Saccharomyces cerevisiae, marketed in dehydrated form, has proved to be an excellent candidate for sedimentation of bacteria. Indeed, it is a unicellular organism that sediments quickly. Centrifugation for 10 min at 5,000 x g is sufficient to form a stable yeast pellet at the bottom of the tube and assures recovery of the bacterial cells. Agar gel quantification before and after this centrifugation showed that whatever the initial amount of bacteria, the addition of dehydrated yeasts (previously resuspended in a sterile Tris solution) in the sample ensures a 100% recovery bacteria. In addition, by adding BSA in solution in a sample, an even stronger pellet can be observed. On the other hand, the use of this BSA solution is an asset for the first rinses because it is known to capture the salts present in a sample and facilitate subsequent PCR even in the presence of inhibitors (King CE, Debruyne R. , Kuch M., Schwarz C., and Poinar HN (2009): Biochemical Techniques, Vol 47, 941-949). More precisely, 200 mg of dehydrated yeast are transferred to a 2 ml tube, then the volume is adjusted to 2 ml with a Tris buffer solution (40 mM and pH 7.6) and then mixed with a Vortex device for 2 hours while stirring. minutes. This gives a suspension of yeast with a concentration of 100 mg / ml. In parallel, a solution of BSA of 60 mg / ml in sterile water is prepared. Then 50mL of seawater sample to be tested is transferred into a 50 ml flask. Then 150 ul of yeast suspension above and 2 ml of BSA solution above are added and homogenized. The yeast suspension thus added at the concentration of 300 μg / ml in the sample forms a cell sieve and, during a centrifugation at a minimum speed of 5000 × g for 10 minutes, entrains all the bacteria present in the sample. the nerve. On the other hand, the BSA at the concentration of 3 mg / ml in the sample makes it possible to make this pellet solid and to avoid its flow during the elimination of the supernatant. The yeast suspension can be prepared either from fresh yeasts or from dehydrated yeasts resuspended in Tris 40mM pH 7.6 buffer to prevent osmotic shock. BSA is rehydrated in sterile water. On the other hand, yeasts do not inhibit subsequent quantitative PCR. In fact, if the protocol is continued until the DNA is extracted, and this DNA is quantitated by quantitative PCR in real time, a yield (measured DNA quantity / initial quantity of bacteria) is obtained. of 1. 2 / - Treatment with ethidium azide The supernatant removed after the first centrifugation for 10 minutes at 5000 g at the temperature of 25 ° C, it remains in the pellet yeasts and all living and dead bacteria initially present in the sample. This pellet is taken up in 15 ml of a 40 mM Tris buffer pH 7.6 and 45 μl of a solution of ethidium azide (EMA) in TMAO (trimethyl amine oxide) are added, the EMA being thus added to the concentration of 3 μg / ml in the sample.

A first short incubation of 30 seconds to 5 minutes, at room temperature and in the dark, allows the EMA to pass through the perforated walls of the dead cells. Then a photoactivation phase makes it possible to bind the ethidium covalently to the DNA. These bonds result in structural modifications of the DNA, which can no longer be quantified by quantitative PCR (no dehybridization, no fixation of the polymerase). This photoactivation is carried out by placing the samples in an ice bucket to avoid its heating. Placed on a stirring table, the sample is homogenized throughout its illumination. For photo activation, a 150 watt halogen lamp is positioned 20 cm above the surface of the sample. The illumination lasts 10 minutes. Under these conditions, the DNA of living bacteria, protected by the impermeable wall, retains its structure and its properties. Once activated by the light, the EMA can no longer act later. The volume of the sample can then be adjusted to 50 ml with Tris buffer and the sample is centrifuged again under the same conditions as before, namely 10 minutes at 5000 g and at 25 ° C. 3 / - Lysis step of the cells by heating and recovery of the sample DNA The above centrifugation makes it possible to reform a pellet consisting of yeasts and living and dead cells. The supernatant can be removed roughly so as to leave only a fraction of about 500 μL containing the solid residue. For this it is enough to return and empty the tube. A short vortexing resuspends the pellet in the residual supernatant. Under the action of heat shock (5 minutes at 95 ° C and 5 minutes in the ice), the cells lyse and release their DNA. A rapid centrifugation of 5 minutes at 25 ° C and 5000 x g is then sufficient to separate the yeast pellet and cell debris from the supernatant in which the DNA is dissolved. 4 / - DNA purification step The supernatant thus contains the DNA to be quantified. However, it is likely to be contaminated by proteins and RNAs released by the bacteria or residual traces of EMA or other molecules possibly present in the initial sample. Quantification by quantitative PCR requires some purity of the sample. Indeed, based on the action of a polymerase, the effectiveness of the technique can be decreased in the presence of inhibitors. The supernatant is thus purified and concentrated either: a) by membrane filtration. All the supernatant is removed and deposited on a Vivacon 500 column (Sartorius stedim, hydrosart membrane) with a retention threshold of 30 000 Da previously rinsed with TE (10 mM Tris, 1 mM EDTA, pH 8). The sample is then rinsed twice with the TE. Filtration is allowed by successive centrifugations at 7000 x g for 10 minutes. Rinses performed, all molecules with a molecular weight of less than 30 kDa were removed and the DNA can be recovered in the volume of TE retained above the membrane by returning the column above a clean tube. b) by fixing-eluting on a silica column. The whole supernatant is mixed with rinsing solutions and then passed on a QlAamp MinElute column (QIA amp DNA Micro Kit, QIAGEN). The DNA contained in the sample will bind to the silica beads contained in the column. After rinsing, the DNA is eluted in 50 μl of TE. The passage of the solutions on the column is carried out by centrifugations of 1 to 3 minutes at 20,000 x g.

The resulting DNA is then pure enough to be quantitated by quantitative PCR. 5 / Quantitative PCR Quantitation Step An MX 3500 P device from the company STRATAGENE and the WIZARD GENOMIC PURIFICATION kit from PROMEGA were used to extract the DNA by adding a step of protein digestion with the proteinase K. Better internal control to check for lack of PCR inhibition in each sample. This control is achieved by adding a known amount of synthetic DNA, hereinafter SEQ. ID. no. 5 seen absent from all chromosomal libraries, in the final sample. The amount of this DNA is measured by quantitative PCR with the SED primers. ID. n ° 6 and 7 which makes it possible to determine if there is an inhibition, and if that is the case to calculate the drift which it drives. Assuming that the inhibition influences both the amplification of synthetic DNA and that of bacterial DNA, the actual amount of bacterial DNA in the sample is deduced. A standard range is needed for each gene targeted by quantitative PCR. In fact, the quantitative PCR apparatus determines the threshold cycle ("cycle threshold" or "ct"), the cycle from which the fluorescence is sufficiently important to be measured. The higher the initial target DNA concentration, the sooner the fluorescence will be quantifiable. To translate this threshold cycle into a quantity of DNA, a minimum standard range of 5 points is therefore necessary. This range is carried out with genomic DNA extracted from the targeted bacterium, purified and quantified in number of copies per microliter or with the synthetic target sequence quantified in number of copies per microliter. The synthetic DNA sequences as well as the oligonucleotides for amplification thereof have been constructed specifically for this technique. Oligonucleotides targeting Escherichia coli-specific genes and enterococci were recovered from the literature. The sensitivity of the quantitative PCR depends on the specificity of the primers used. Three pairs of primers were tested for E. coli: a pair of primers targeting a sequence of the uidA gene specific for E. coli and coding for 8-glucuronidase (protein assayed by the enzymatic method). a pair targeting the 16S gene which is also specific for E. coli, and which, being present in several copies in the genome (5 to 7 copies), allows a more sensitive detection, and therefore a lower threshold. a pair targeting the LacZ gene, but these non-specific E. coli primers were eliminated. The 16S gene primers were favored for the study because, for samples with low chromosome concentration, the uidA gene primers showed concatamers of oligonucleotides preventing the exact measurement of gene copy number. Different concentrations (homo-concentrations and heteroconcentrations) in primers in the reaction volume were tested, changes in duration and / or temperature during the elongation phase were also studied, but none of the conditions tested allowed to eliminate the formation of these dimers and / or concatemers. Two pairs of primers were tested for Enterococci. - 23S-targeted primers, specific to enterococci, - A pair targeting a sequence of the gene encoding the Tuf protein just as specific to Enterococci. This second pair was favored for the quantification of enterococci because the amplification and quantification of the targeted sequence can be performed using the same quantitative PCR protocol as that of the quantification of E. coli. The pair of oligonucleotides used to quantify the number of chromosomes of E. coli proposed by Malinen et al (2003) (Comparison of real-time PCR with SYBR Green I or 59-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide Microbiology, Vol 149, pp. 269-277), targeting the 16S gene of E. coli alone, shows the following sequences Ecolil6s Fw: SEQ. ID. No. 1 = 5 '- GTTAATACCTTTGCTCATTGA - 3 Ecolilers Rv: SEQ. ID. n ° 2 = 5 '- ACCAGGGTATCTAATCCTGTT - 3' The pair of primers used to quantify the number of enterococcal chromosomes established by Morrison et al (2008): (Quantification of enterococci and bifidobacteria in Georgia estuaries Research, Vol 42, pp. 4001-4009) targeting the Enterococci Tuf protein gene, has the following sequences EnteroTuf Fw: SEQ. ID. No. 3 = 5 '- TACTGACAAACCATTCATGATG - 3' EnteroTuf Rv: SEQ. ID. # 4 = 5 '- AACTTCGTCACCAACGCGAAC - 3'. Each analysis is independent and has been optimized with SYBR Green Kit but the amplification and quantification of the target sequences of E. coli and enterococci can be performed simultaneously during the same PCR program. With the primer pairs used at the concentration of 0.4 μM, each amplification cycle contains only two steps: a dehybridization step at 95 ° C for 5 seconds followed by a TaqPolymerase binding and polymerization step at 60 ° C for 25 seconds. The level of fluorescence in each well is measured at the end of each cycle. A fusion curve of the amplified DNA is produced at the end of the amplification cycles, it makes it possible to verify the amplification of a single and specific sequence. The quantitative PCR apparatus then estimates the initial copy number of target sequence in the test portion of each sample. Taking into account the final volume of the sample and the drift due to the inhibition, the initial concentration of bacteria in the sample can be determined. The internal synthetic DNA control sequence called the alien sequence and its amplification primers were the following sequences: Alien sequence = SEQ. ID. # 5 = 5 '- CCCATTCATCTGCCAGCTAGCAGACGGGCACAACGGGTCAACATATTGCTGCTT GGACTTAAGTTACGCTAGAGGTTTCTATGGGCCAGGTGCATAAGGATGCTCTC CCA - 3' Ali Fw: SEQ. ID. # 6 = 5'-GGGTAAGTAGACGGTCGATC - 3 'Ali Rv: SEQ. ID. Example 2: Influence of EMA Concentration and Illumination Treatment. 2.1 / - Influence of EMA concentration on DNA binding of living and dead cells.

DNA quantification assays on previously treated samples with varying concentrations of ethidium azide of 3, 6 and 12 μg / ml were performed. Three types of samples were tested, samples consisting only of living or dead (non-lysed) bacteria and mixed samples containing 10 times more unpolluted dead cells than living cells in 50 ml of filtered seawater. Figure 1 shows the details and results of the experiment. Yield (%) is the ratio of the number of chromosomes measured to the initial amount of bacteria in the sample. Following a 20-minute exposure under a halogen lamp (150 W), only the concentration of 3 μg / ml sample EMA seems suitable. In fact, after treatment with ethidium azide at concentrations of 6 μg / ml and 12 μg / ml, no chromosome is quantified in samples containing living bacteria only. On the other hand, after treatment with ethidium azide at the concentration of 3 μg / ml, in a mixed sample, the quantitative PCR makes it possible to quantify 96% of the chromosomes of living bacteria. The EMA seems to act primarily on dead cells. On the other hand, this concentration appears sufficient to treat all the DNA of dead cells. Indeed, in a sample consisting solely of dead cells, after such a treatment, the quantitative PCR does not quantify anything. However, the treatment proves to be too powerful because in a sample made up of living cells only, the quantitative PCR quantifies only 53% of the chromosomes. Under these conditions, the EMA destroys part of the DNA of living cells in the absence of a dead cell. 2.2 / Influence of the illumination treatment on the DNA binding of the cells DNA quantification tests on samples treated with 3 g / ml ethidium azide during variable illumination times (10 and 20 minutes) were made. Three types of samples are tested, samples consisting only of living or dead (non-lysed) bacteria, and mixed samples containing 10 times more dead non-lysed cells than live cells in 50 ml of filtered seawater. Figure 2 presents the details and results of the experiment. Yield (%) is the ratio of the number of chromosomes measured to the initial amount of bacteria in the sample. While EMA at 3 μg / ml also acts on the DNA of living cells when the illumination phase is 20 minutes, 10 minutes of illumination is sufficient to bridge all of the dead cell DNA. Free DNA, while avoiding the action of EMA on living cells in a sample devoid of dead bacteria. On the other hand, it is important to note that a count on agar media after the EMA treatment does not measure the number of living cells in the sample. Indeed, even if it does not damage the DNA of living bacteria, ethidium azide seems to damage living cells and disrupt their development. Example 3: Condition for carrying out the step of extraction of the DNA by heating as a function of the incubation time at 95 ° C. Step 3 of extraction of the bacterial DNA, all the DNA free as well as that of dead bacteria is bridged by the EMA. The DNA of living bacteria must now be released into the medium in order to be recovered and assayed by quantitative PCR. Incubation in a water bath heated to 95 ° C followed by incubation in ice allows the bacteria to be lysed. However, incubation at 95 ° C too long alters the DNA released by the cells after lysis.

Figure 3 presents the results of the test which made it possible to determine the optimal duration of this incubation time of the sample. It can be noted that the amount of chromosomes estimated by the quantitative PCR decreases as a function of the incubation time at 95 ° C. 5 minutes are required to lyse all cells, regardless of the initial bacterial concentration. Beyond 5 minutes, it is noted that the number of chromosomes measured by quantitative PCR decreases. An incubation period of 5 minutes is sufficient and avoids certain damage to the bacterial DNA after lysis of the cells.

Claims (15)

REVENDICATIONS1. A method for quantifying living bacteria in a liquid medium, preferably an aqueous medium, capable of containing them, characterized in that the following successive steps are carried out in which: a) yeasts are added to said sample and a mixing is carried out with stirring, and b / separating a solid residue consisting of a precipitate containing all yeasts and bacteria contained in said sample, c) suspending said solid residue in a buffered solution at pH 7 to 8, preferably a 40 mM Tris buffer at pH 7.6 and added therein a chemical or biological compound, suitable, under concentration and / or treatment conditions, to cause the binding of said compound specifically to the DNA of dead bacteria without causing lysis or degradation of the walls of living bacteria or the DNA binding of living bacteria, said compound known as an inhibitory compound being able to thus prevent amplification by PCR of the DNA which is bound to it, and d / separating a fraction containing a solid residue containing all the yeasts and bacteria, and e / it is heated said solid residue, preferably in a water bath, at a step temperature more than 100 ° C, preferably at 95 ° C for 5 to 10 minutes, so as to lyse all bacteria without causing yeast lysis, and f / a fraction containing all the yeasts and debris of lysed bacteria is separated and recovering a fraction containing the bacterial DNA, and performing quantification by PCR amplification, preferably by real-time PCR, of the DNA from said initially living bacteria in the starting sample. 2. Method according to claim 1, characterized in that in step g /, one carries out the quantification of living bacteria of the genus enterococci and Escherichia Coli contained in a bathing water sample. 3. Method according to one of claims 1 or 2, characterized in that in step b /, centrifugation of the sample at least 5,000 g in a container for at least 10 minutes and recovering the pellet by removing the supernatant. 4. Process according to claim 1 to 3, characterized in that in step a), Saccharomyces cerevisiae baker's yeast is used, the yeast concentration being adjusted to a value of 200 to 400 μg / ml. 5. Method according to claim 4, characterized in that in step a /, is added further in the sample a coagulant protein such as bovine serum albumin (BSA) at a concentration of 2 to 20 mg / ml in the sample to promote adhesion of the pellet on the wall of the centrifuge vessel in step b /. 6. Method according to one of claims 1 to 5, characterized in that in step cl, said inhibiting compound is a photo-activatable intercalating agent and the suspension is subjected to an activation light irradiation treatment binding said intercalating agent with the DNA of dead bacteria, said intercalating agent inhibiting PCR amplification of said DNA to which it is bound. 7. Process according to claim 6, characterized in that said intercalating agent is an ethidium azide, preferably EMA, at a concentration of 2 to 5 μg / ml and the suspension is subjected to a light irradiation, while maintaining a suspension temperature at room temperature, preferably by soaking the container containing it in the ice. 8. Method according to one of claims 1 to 7, characterized in that in step dl, one carries out said separation by centrifugation of the suspension obtained after the treatment of step c, at least 5000 g for at least 10 minutes and removal of most of the supernatant to recover the pellet containing said solid residue containing all yeasts and bacteria in a small fraction of at least 500 μl of said suspension, and heated to the step e /. 9. Method according to one of claims 1 to 8, characterized in that in step d /, is recovered at least 99% of the bacteria initially contained in the sample. 10. Method according to one of claims 1 to 9, characterized in that in step f /, is carried out said separation by centrifugation of the suspension obtained after the treatment of step c, at least 5000 g for at least 5 minutes and removing the pellet containing intact yeasts and lysed bacteria debris, to recover the supernatant containing said bacterial DNA. 11. Method according to one of claims 1 to 10, characterized in that in step g / is carried out a preliminary step of purification of the bacterial DNA, preferably on a silica column or a threshold membrane filtration column. 30 KDa. 12. Method according to one of claims 1 to 11, characterized in that in step g / is amplified E. coli bacteria and enterococci with the following pair of primers: - for E. coli bacteria: a specific sequence derived from the 16S- gene for enterococcal bacteria: a specific sequence of the genus Enterococcus derived from the tuf gene. 13. The method of claim 12, characterized in that step g / is added in the DNA sample to quantify a known concentration of non-bacterial synthetic DNA called alien DNA. 14. Method according to one of claims 12 or 13, characterized in that the following oligonucleotides chosen from: - SEQ. ID. No. 1 and 2 for the 5 'and 3' primers of E. Coli bacteria, and - SEQ. ID. Nos. 3 and 4 for the 5 'and 3' primers of enterococci, and SEQ. ID. No. 5 for the internal control sequence of alien DNA, and SEQ. ID. No. 6 and 7 for the primers 5 'and 3' of the sequence SEQ. ID. # 5. 15. Method according to one of claims 1 to 14, characterized in that concentrations of 2 to 108 live bacteria / ml of samples can be detected.